Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy | Zendy

JeanMarc Lacombe | Zendy; François Boué | Zendy; Sophie Grabar | Zendy; N. Viget | Zendy; Sandrine Gazaignes | Zendy; Anne-Sophie Lascaux-Cametz | Zendy; Jérôme Pacanowski | Zendy; Marialuisa Partisani | Zendy; Odile Launay | Zendy; Sophie Matheron | Zendy; Éric Rosenthal | Zendy; É. Rouveix | Zendy; Pierre Tattevin | Zendy; Pierre de Truchis | Zendy; Dominique Costagliola | Zendy; James J. Goedert | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy

Author(s) -

JeanMarc Lacombe,

François Boué,

Sophie Grabar,

N. Viget,

Sandrine Gazaignes,

Anne-Sophie Lascaux-Cametz,

Jérôme Pacanowski,

Marialuisa Partisani,

Odile Launay,

Sophie Matheron,

Éric Rosenthal,

É. Rouveix,

Pierre Tattevin,

Pierre de Truchis,

Dominique Costagliola,

James J. Goedert

Publication year - 2012

Publication title -

aids

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.195

H-Index - 216

eISSN - 1473-5571

pISSN - 0269-9370

DOI - 10.1097/qad.0b013e32835cba6c

Subject(s) - cart , sarcoma , medicine , poisson regression , incidence (geometry) , kaposi's sarcoma , relative risk , confidence interval , cohort , viral load , gastroenterology , surgery , human immunodeficiency virus (hiv) , immunology , pathology , population , mechanical engineering , physics , human herpesvirus , environmental health , optics , engineering

To determine whether incident AIDS-defining Kaposi sarcoma or Pneumocystis jiroveci pneumonia (PJP) is associated with combination antiretroviral therapy (cART) initiation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research